Newcastle and Doxorubicin attenuated against diethylnitrosoamine as antitumor effects which induced hepatocellular carcinoma

Newcastle and Doxorubicin attenuated against diethylnitrosoamine as anti-proliferative and immunosuppresor effects which induced hepatocellular carcinoma

GFBR3 Promoter Methylation Is A Prognostic Indicator And Not Responding To Decitabine Treatment In Hepatocellular Carcinoma

Effect of 5-Azacytidine as A Demethylation Agent on PCNA and RB1 Genes in Hepatocellular Carcinoma Cell Model “HepG2”

In vitro assessment of cytotoxic and genotoxic activities of the anticancer drug doxorubicin

Effect of Doxorubicin and Cisplatin on Alpha-fetoprotein levels in Hepatocellular Carcinoma Cell lines

COMPARING ANTIPROLIFERATIVE AND PROAPOPTOTIC EFFECTS OF THE PAN-DEACETYLASE INHIBITOR PANOBINOSTAT WITH DOXORUBICIN ON HEPG2 HEPATOCELLULAR CARCINOMA CELL LINE

Biochemical Study in Ehrlich Carcinoma Cells-bearing Mice Treated with Arsenic Trioxide and Cisplatin

Resveratrol inhibits epithelial-mesenchymal transition in hepatocellular carcinoma

Promoter methylation of certain tumor regulatory genes and hepatocellular carcinoma